Industry News
Most of Spain and all of Portugal were hit by a major blackout that impacted public transport, airports and phone service.
Via: Claims Journal
Deel Inc., a $12 billion Silicon Valley startup, is escalating a bitter legal fight with its top rival in the market for human resources and payroll software. The company has filed a defamation lawsuit in Delaware state court against People …
Via: Claims Journal
The family of one of three college students who died in a Cybertruck crash in California filed a lawsuit in a bid to gain access to the Tesla Inc. pickup and better understand how their daughter died. The driver and …
Via: Claims Journal
It’s not often that applause breaks out in the audience after a vote at the Hawaiʻi Legislature, but that one afternoon last week. The measure was House Bill 1001, and the subject was settling claims related to the August 2023 …
Via: Claims Journal
Xceedance named Gavin Lillywhite senior vice president, operating leader for the U.K. and Europe. Lillywhite will lead operations across the U.K. and Europe. Lillywhite has more than 30 years of international experience. He most recently held senior leadership roles focused …
Via: Claims Journal
DoorDash Inc. asked a California judge to dismiss Uber Technologies Inc.’s anticompetition lawsuit against it, arguing that Uber is using an “ill-fitting” state law to justify its claims. DoorDash, which has two-thirds of the U.S. food delivery market, argued in …
Via: Claims Journal
Marks & Spencer stopped taking online orders in the U.K. and Ireland on Friday following a cyber attack which it reported earlier in the week, an announcement which sent its shares down by 5%. The British company, which sells its …
Via: Claims Journal
Insurers in the U.S. paid out $1.6 billion as the number of dog-related injury claims rose significantly in 2024.
Via: Claims Journal
The company that owned the railcar that caused the devastating East Palestine train derailment in 2023 won’t have to help pay for the $600 million settlement Norfolk Southern agreed to with residents. An Ohio jury decided Wednesday that GATX isn’t …
Via: Claims Journal
A biotech company is suing Merck & Co. over its easier-to-use version of its blockbuster cancer treatment Keytruda, alleging the pharmaceutical giant violated its intellectual property. Merck knowingly infringed Halozyme Therapeutics Inc.’s patents in crafting a version of Keytruda that …
Via: Claims Journal